+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The effect of ursodeoxycholic acid urso in primary sclerosing cholangitis a comparison to primary biliary cirrhosis



The effect of ursodeoxycholic acid urso in primary sclerosing cholangitis a comparison to primary biliary cirrhosis



Gastroenterology 94(5 Part 2): A595




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 029337483

Download citation: RISBibTeXText


Related references

Treatment of primary biliary cirrhosis and primary sclerosing cholangitis: use of ursodeoxycholic acid. Current Gastroenterology Reports 1(1): 38-41, 2000

Ursodeoxycholic acid in the treatment of primary biliary cirrhosis and primary sclerosing cholangitis in pregnancy. Hepatology 36(4 Part 2): 491A, 2002

Urinary excretion of ursodeoxycholic acid during treatment of patients with primary biliary cirrhosis and primary sclerosing cholangitis. Journal of Hepatology 7, 1988

Comparative effects of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis and primary sclerosing cholangitis. Clinical Research 37(2): 365A, 1989

Ursodeoxycholic acid therapy plays an immunomodulatory and anti-apoptotic role in patients with primary sclerosing cholangitis and primary biliary cirrhosis. Journal of Hepatology 38(Suppl. 2): 208, 2003

Single dose or multiple doses of ursodeoxycholic acid are equally effective in the treatment of primary sclerosing cholangitis and primary biliary cirrhosis. Gastroenterology 108(4 Suppl. ): A1191, 1995

Treatment of the primary biliary cirrhosis and sclerosing cholangitis with ursodeoxycholic acid. Journal of Hepatology 25(Suppl. 1): 210, 1996

Ursodeoxycholic acid therapy affects the cytokine network and plays an immunomodulatory role in patients with primary sclerosing cholangitis and primary biliary cirrhosis. Hepatology 36(4 Part 2): 499A, 2002

Effect of ursodeoxycholic acid urso and colchicine c on the progression of primary biliary cirrhosis pbc. Gastroenterology 100(5 Part 2): A740, 1991

High-dose ursodeoxycholic acid in the treatment of primary sclerosing cholangitis: throwing the urso out with the bathwater?. Hepatology 50(3): 671-673, 2009

Ulcerative colitis uc disease activity after treatment of associated primary sclerosing cholangitis psc with ursodeoxycholic acid urso or placebo. Gastroenterology 102(2 Part 2): A690, 1992

Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitis. Hepatology 40(3): 693-698, 2004

Effect of colitis and ileoanal pouch on biliary enrichment of ursodeoxycholic acid in primary sclerosing cholangitis. Digestive Diseases and Sciences 51(3): 618-622, 2006

Ursodeoxycholic acid and biliary bile acid composition in primary sclerosing cholangitis Effect of Apo E phenotype. Gastroenterology 123(1 Suppl.): 65, 2002

Long term ursodeoxycholic acid (URSO) treatment improves glutathione status in primary biliary cirrhosis (PBC). Journal of Hepatology 36(Supp-S1): 155-156, 2002